Interacting moving bottlenecks in traffic flow
Networks and Heterogeneous Media · 2023 · 18 (2) · 930-945
DOI: 10.3934/nhm.2023040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Networks and Heterogeneous Media, 2023. Verfasst von Paola Goatin und 3 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
We present a general multi-scale approach for modeling the interaction of controlled autonomous vehicles (AVs) with the surrounding traffic flow. The model consists of a scalar conservation law for the bulk traffic, coupled with ordinary differential equations describing the possibly interacting AV trajectories. The coupling is realized through flux constraints at the moving bottleneck positions, inducing the formation of non-classical jump discontinuities in the traffic density. In turn, AVs are forced to adapt their speed to the downstream traffic average velocity in congested situations. We analyze the model solutions in a Riemann-type setting, and propose an adapted finite volume scheme to compute approximate solutions for general initial data. The work paves the way to the study of general optimal control strategies for AV velocities, aiming at improving the overall traffic flow by reducing congestion phenomena and the associated externalities.
Zitieren
APA
Goatin, P., Daini, C., Monache, M. L. D., & Ferrara, A. (2023). Interacting moving bottlenecks in traffic flow. Networks and Heterogeneous Media, 18(2), 930-945. https://doi.org/10.3934/nhm.2023040
Vancouver
Goatin P, Daini C, Monache MLD, Ferrara A. Interacting moving bottlenecks in traffic flow. Networks and Heterogeneous Media. 2023;18(2):930-945. doi:10.3934/nhm.2023040
BibTeX
@article{Goatin2023,
author = {Goatin, Paola and Daini, Chiara and Monache, Maria Laura Delle and Ferrara, Antonella},
title = {Interacting moving bottlenecks in traffic flow},
journal = {Networks and Heterogeneous Media},
year = {2023},
volume = {18},
number = {2},
pages = {930--945},
doi = {10.3934/nhm.2023040}
}
EUVIMED